Itay Nitzan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Itay Nitzan has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Inbal Akavian
Department of Obstetrics and Gynecology Hadassah Medical Organization and Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
6 shared publications - Tomer Talmy
Israel Defense Forces Medical Corps, Tel Hashomer, Ramat Gan (A.M.T., T.T., D.T., A.F.).
6 shared publications Arnon Afek
The Gertner Institute for Epidemiology and Health Policy Research (G.T., A.A.), Sheba Medical Center, Ramat Gan, Israel
5 shared publicationsInbal Akavian
Faculty of Medicine (I.N., S.K., N.S., T.S., O.S., N.L., I.A., I.C., J.L.), The Hebrew University of Jerusalem, Jerusalem, Israel; Department of Obstetrics and Gynecology (I.A.), Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5 shared publications- Margarita Safir
Department of Ophthalmology, Rabin Medical Center, Petah Tikva 4941492, Israel
5 shared publications - Bar Cohen
Israel Defense Forces Medical Corps, Surgeon General’s Headquarters, Ramat Gan, Israel
4 shared publications
Latest Publications
- 19 November 2026
- Published by Springer Nature in Eye
Idiopathic orbital inflammation: a changing disease or a changing label?
- 19 November 2026
- Published by Springer Nature in Eye
Idiopathic orbital inflammation: a changing disease or a changing label?
- Open Access
- 24 September 2026
- Published by S. Karger AG in Case Reports in Ophthalmology
Anterior Defocusing of the Nd:YAG Laser Aiming Beam for Treatment ofPremacular Sub-Internal Limiting Membrane (Sub-ILM) Hemorrhage: A CaseReport
Introduction: Chromatic aberration causes a depth-dependent mismatch between the visible diode aiming beam and the 1064-nm Nd:YAG treatment beam, which may be clinically relevant during posterior segment laser procedures. We report the clinical application of anterior defocusing of the aiming beam in the treatment of premacular sub-internal limiting membrane (sub-ILM) hemorrhage. Case Presentation: A 23-year-old man developed acute bilateral visual loss in the setting of severe thrombocytopenia after failed bone marrow transplantation. Examination showed a large premacular sub-ILM hemorrhage in the left eye and a smaller premacular sub-ILM hemorrhage with associated intraretinal hemorrhages in the right eye. Presenting visual acuity was finger counting at 1 meter in the right eye and 0.12 in the left eye. The left eye underwent Nd:YAG membranotomy using a Nidek YC-1800 laser with 300 µm of anterior defocusing and a single 2.0 mJ pulse. Immediate drainage of preretinal blood into the vitreous was achieved. At 10 months, visual acuity improved to 0.8 in the treated left eye, whereas the untreated right eye remained finger counting at 1 meter. Optical coherence tomography demonstrated a focal opening in the internal limiting membrane, with no structural abnormalities noted in the underlying retina. Conclusion: This case illustrates the practical value of compensating for chromatic aberration during posterior segment Nd:YAG laser treatment. Anterior defocusing of the aiming beam may improve treatment precision and enhance procedural safety in selected cases of premacular sub-ILM hemorrhage.
- 24 September 2026
- Published by S. Karger AG in Case Reports in Ophthalmology
Open AccessAnterior Defocusing of the Nd:YAG Laser Aiming Beam for Treatment ofPremacular Sub-Internal Limiting Membrane (Sub-ILM) Hemorrhage: A CaseReport
Introduction: Chromatic aberration causes a depth-dependent mismatch between the visible diode aiming beam and the 1064-nm Nd:YAG treatment beam, which may be clinically relevant during posterior segment laser procedures. We report the clinical application of anterior defocusing of the aiming beam in the treatment of premacular sub-internal limiting membrane (sub-ILM) hemorrhage. Case Presentation: A 23-year-old man developed acute bilateral visual loss in the setting of severe thrombocytopenia after failed bone marrow transplantation. Examination showed a large premacular sub-ILM hemorrhage in the left eye and a smaller premacular sub-ILM hemorrhage with associated intraretinal hemorrhages in the right eye. Presenting visual acuity was finger counting at 1 meter in the right eye and 0.12 in the left eye. The left eye underwent Nd:YAG membranotomy using a Nidek YC-1800 laser with 300 µm of anterior defocusing and a single 2.0 mJ pulse. Immediate drainage of preretinal blood into the vitreous was achieved. At 10 months, visual acuity improved to 0.8 in the treated left eye, whereas the untreated right eye remained finger counting at 1 meter. Optical coherence tomography demonstrated a focal opening in the internal limiting membrane, with no structural abnormalities noted in the underlying retina. Conclusion: This case illustrates the practical value of compensating for chromatic aberration during posterior segment Nd:YAG laser treatment. Anterior defocusing of the aiming beam may improve treatment precision and enhance procedural safety in selected cases of premacular sub-ILM hemorrhage.
- Open Access
- 24 September 2026
- Published by Frontiers Media SA in Frontiers in Ophthalmology
- Vol. 6, 1972892
Mentorship as metadata: clinical annotation and the limits of real-world data in oculoplastic surgery
In oculoplastic surgery, real-world databases capture diagnosis and procedure codes but rarely the clinical variables that define surgical meaning: laterality, levator function, margin-reflex distance, inflammatory activity, operative intent, or the reason for revision. We propose that clinical supervision be recorded as documented clinical interpretive annotation : an explicit, written layer that defines the limits of routinely collected data before they are analyzed. “Mentorship as metadata” names the educational relationship that produces this annotation and is used throughout as a labelled metaphor, not as a claim of equivalence with formal metadata, data provenance, or research-governance documentation. Synthesizing established reporting and causal-inference frameworks with recently published oculoplastic database studies (2019–2026), we develop a three-layer model: code, phenotype, and judgment, together with a pre-analysis phenotype map that trainees and mentors can complete before a query is run. Central to this framework is the “refusal point”: a documented, pre-specified boundary at which a dataset should not be used to answer a given clinical question, co-signed by the oculoplastic mentor, the trainee or lead analyst, and a methodologist and recorded as a routine study-design deliverable. The refusal point complements the estimand and target-trial frameworks by naming the adjacent, more tempting question that the data cannot answer. It introduces no new statistical construct; its contribution is documentary, procedural, and educational, and we state explicitly what each existing framework already requires and what remains unspecified. We advance one falsifiable hypothesis: that pre-specified, co-signed refusal-point documentation increases pre-analysis reframing of research questions and improves concordance between the protocol estimand and the estimand the published conclusions can support, and we set out a prospective programme capable of refuting it. Real-world data remain valuable for utilization, trends, and rare associations, but they are not self-interpreting. Training oculoplastic surgeon-scientists to name, in writing and before analysis, the boundary between code and clinical reality may make database research more transparent, restrained, and reproducible. In oculoplastics, mentorship is the clinical annotation that turns data into evidence.
- 24 September 2026
- Published by Frontiers Media SA in Frontiers in Ophthalmology
- Vol. 6, 1972892
Open AccessMentorship as metadata: clinical annotation and the limits of real-world data in oculoplastic surgery
In oculoplastic surgery, real-world databases capture diagnosis and procedure codes but rarely the clinical variables that define surgical meaning: laterality, levator function, margin-reflex distance, inflammatory activity, operative intent, or the reason for revision. We propose that clinical supervision be recorded as documented clinical interpretive annotation : an explicit, written layer that defines the limits of routinely collected data before they are analyzed. “Mentorship as metadata” names the educational relationship that produces this annotation and is used throughout as a labelled metaphor, not as a claim of equivalence with formal metadata, data provenance, or research-governance documentation. Synthesizing established reporting and causal-inference frameworks with recently published oculoplastic database studies (2019–2026), we develop a three-layer model: code, phenotype, and judgment, together with a pre-analysis phenotype map that trainees and mentors can complete before a query is run. Central to this framework is the “refusal point”: a documented, pre-specified boundary at which a dataset should not be used to answer a given clinical question, co-signed by the oculoplastic mentor, the trainee or lead analyst, and a methodologist and recorded as a routine study-design deliverable. The refusal point complements the estimand and target-trial frameworks by naming the adjacent, more tempting question that the data cannot answer. It introduces no new statistical construct; its contribution is documentary, procedural, and educational, and we state explicitly what each existing framework already requires and what remains unspecified. We advance one falsifiable hypothesis: that pre-specified, co-signed refusal-point documentation increases pre-analysis reframing of research questions and improves concordance between the protocol estimand and the estimand the published conclusions can support, and we set out a prospective programme capable of refuting it. Real-world data remain valuable for utilization, trends, and rare associations, but they are not self-interpreting. Training oculoplastic surgeon-scientists to name, in writing and before analysis, the boundary between code and clinical reality may make database research more transparent, restrained, and reproducible. In oculoplastics, mentorship is the clinical annotation that turns data into evidence.
- Open Access
- 28 August 2026
- Published by Springer Nature in Digestive Diseases and Sciences
- p. 1-9
Irritable Bowel Syndrome and Allergic Diseases: A Nationwide Study of 1.5 Million Adolescents
- 28 August 2026
- Published by Springer Nature in Digestive Diseases and Sciences
- p. 1-9
Open AccessIrritable Bowel Syndrome and Allergic Diseases: A Nationwide Study of 1.5 Million Adolescents
- Open Access
- 19 August 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (4) , 1051-1060
Ketamine administration and postoperative mortality after major cancer surgery: a propensity-matched population-based study
- 19 August 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (4) , 1051-1060
Open AccessKetamine administration and postoperative mortality after major cancer surgery: a propensity-matched population-based study
- Open Access
Adverse pregnancy outcomes in women with migraine: A retrospective multicenter cohort study
Objective: Migraine affects 15%–20% of women of reproductive age, with peak incidence during the childbearing years. While prior studies have demonstrated an association between migraine and hypertensive disorders of pregnancy, data on other outcomes and differences between migraine subtypes remain limited. This study aimed to evaluate the relationship between migraine and a comprehensive range of obstetric complications. Methods: We conducted a historical cohort study using the TriNetX US Collaborative Network, which includes anonymized electronic medical records from 70 US healthcare organizations between 2005 and 2025. Pregnant women aged 18–40 with a prepregnancy migraine diagnosis and no prepregnancy hypertension diagnosis were matched 1:1 to pregnant women without migraine ( n = 176,287 per group) using propensity scores based on age, race and ethnicity, BMI, tobacco or substance use during pregnancy, multiple gestation, thyroid disorders, chronic kidney disease, diabetes mellitus, socioeconomic factors, and psychiatric comorbidities. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for adverse outcome in the migraine group compared with the matched control group. Results: Women with migraine had significantly higher risks of multiple adverse pregnancy outcomes compared with matched controls. The strongest associations were observed for hypertensive disorders, including eclampsia (OR, 1.69; 95% CI, 1.45–1.96; 0.26% vs. 0.15%), preeclampsia (OR, 1.45; 95% CI, 1.41–1.49; 6.03% vs. 4.25%), and gestational hypertension (OR, 1.47; 95% CI, 1.43–1.51; 8.47% vs. 5.92%), as well as preterm birth (OR, 1.36; 95% CI, 1.31–1.40; 5.80% vs. 4.35%). Elevated risks were also observed for miscarriage, placental abruption, intrauterine fetal demise, and gestational diabetes mellitus. Risks were similar across migraine subtypes (with vs. without aura). Conclusion: This large, propensity score–matched cohort study demonstrates that migraine independently increases the risk of multiple adverse pregnancy outcomes, with the strongest effects seen in vascular complications such as hypertensive disorders, as well as preterm birth. The consistent pattern of elevated risks across diverse outcomes suggests common underlying mechanisms, likely involving vascular dysfunction and inflammatory pathways. These findings indicate that migraine should be considered an important risk marker in pregnancy.
Open AccessAdverse pregnancy outcomes in women with migraine: A retrospective multicenter cohort study
Objective: Migraine affects 15%–20% of women of reproductive age, with peak incidence during the childbearing years. While prior studies have demonstrated an association between migraine and hypertensive disorders of pregnancy, data on other outcomes and differences between migraine subtypes remain limited. This study aimed to evaluate the relationship between migraine and a comprehensive range of obstetric complications. Methods: We conducted a historical cohort study using the TriNetX US Collaborative Network, which includes anonymized electronic medical records from 70 US healthcare organizations between 2005 and 2025. Pregnant women aged 18–40 with a prepregnancy migraine diagnosis and no prepregnancy hypertension diagnosis were matched 1:1 to pregnant women without migraine ( n = 176,287 per group) using propensity scores based on age, race and ethnicity, BMI, tobacco or substance use during pregnancy, multiple gestation, thyroid disorders, chronic kidney disease, diabetes mellitus, socioeconomic factors, and psychiatric comorbidities. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for adverse outcome in the migraine group compared with the matched control group. Results: Women with migraine had significantly higher risks of multiple adverse pregnancy outcomes compared with matched controls. The strongest associations were observed for hypertensive disorders, including eclampsia (OR, 1.69; 95% CI, 1.45–1.96; 0.26% vs. 0.15%), preeclampsia (OR, 1.45; 95% CI, 1.41–1.49; 6.03% vs. 4.25%), and gestational hypertension (OR, 1.47; 95% CI, 1.43–1.51; 8.47% vs. 5.92%), as well as preterm birth (OR, 1.36; 95% CI, 1.31–1.40; 5.80% vs. 4.35%). Elevated risks were also observed for miscarriage, placental abruption, intrauterine fetal demise, and gestational diabetes mellitus. Risks were similar across migraine subtypes (with vs. without aura). Conclusion: This large, propensity score–matched cohort study demonstrates that migraine independently increases the risk of multiple adverse pregnancy outcomes, with the strongest effects seen in vascular complications such as hypertensive disorders, as well as preterm birth. The consistent pattern of elevated risks across diverse outcomes suggests common underlying mechanisms, likely involving vascular dysfunction and inflammatory pathways. These findings indicate that migraine should be considered an important risk marker in pregnancy.
- 20 July 2026
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (5) , e254
Re: Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Thyroid Eye Disease
Was not provided for this article.
- 20 July 2026
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (5) , e254
Re: Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Thyroid Eye Disease
Was not provided for this article.
- Open Access
- 2 July 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (5) , 1209-1214
Childhood overweight and obesity as risk factors for astigmatism: a longitudinal analysis
- 2 July 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (5) , 1209-1214
Open AccessChildhood overweight and obesity as risk factors for astigmatism: a longitudinal analysis
- 29 May 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (2) , 625-627
Risk of postoperative respiratory complications in adults treated with GLP-1 receptor agonists: a propensity-matched population-based study
- 29 May 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (2) , 625-627
Risk of postoperative respiratory complications in adults treated with GLP-1 receptor agonists: a propensity-matched population-based study
- 21 May 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (3) , 665-669
Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes
- 21 May 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (3) , 665-669
Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes